- Home
- EBS vs RCKT Comparison
EBS vs RCKT Comparison
Compare EBS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBS | RCKT |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.1M | 401.6M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBS | RCKT |
|---|---|---|
| Price | $8.00 | $3.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $12.00 | ★ $29.73 |
| AVG Volume (30 Days) | 638.8K | ★ 3.8M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.83 | N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $742,900,000.00 | N/A |
| Revenue This Year | $1.29 | N/A |
| Revenue Next Year | N/A | $64.28 |
| P/E Ratio | $8.66 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.71 | $2.19 |
| 52 Week High | $14.06 | $8.26 |
Technical Indicators
Market Signals| Indicator | EBS | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 41.22 |
| Support Level | $7.73 | $3.32 |
| Resistance Level | $8.54 | $4.08 |
| Average True Range (ATR) | 0.34 | 0.19 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 21.09 | 25.17 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.